[HTML][HTML] Immunologic dysregulation and hypercoagulability as a pathophysiologic background in COVID-19 infection and the immunomodulating role of colchicine
DA Vrachatis, KA Papathanasiou, SG Giotaki… - Journal of Clinical …, 2021 - mdpi.com
In 2020, SARS-COV-2 put health systems under unprecedented resource and manpower
pressure leading to significant number of deaths. Expectedly, researchers sought to shed …
pressure leading to significant number of deaths. Expectedly, researchers sought to shed …
[引用][C] Can we still consider treatment with colchicine effective in SARS-COV-2 infection? Systematic review, meta-analysis, and trial sequential analysis.
E De-Miguel-Balsa, R Estevan-Ortega… - Eur Rev Med Pharmacol Sci, 2021